Drugs: From Discovery to Approval (Record no. 295532)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02228nam a2200169Ia 4500 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780470195109 |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.19 RIC-D |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Rick NG |
| 245 ## - TITLE STATEMENT | |
| Title | Drugs: From Discovery to Approval |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 2nd ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Wiley-Blackwell |
| Date of publication, distribution, etc. | 2009 |
| Place of publication, distribution, etc. | Hoboken, New Jersey |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | xiii, 466 pages : illustrations ; 24 cm |
| 505 ## - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Drug discovery : targets and receptors -- Drug discovery : small molecule drugs -- Drug discovery : large molecule drugs -- Drug development and preclinical studies -- Clinical trial -- Regulatory authorities -- Regulatory applications -- Good manufacturing practice : regulatory requirements -- Good manufacturing practice : drug manufacturing -- Future perspectives. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The new edition of this best-selling book continues to offer a user-friendly, step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of pre-clinical studies, the conduct of human clinical trials, regulatory controls, and even the manufacturing processes for pharmaceutical products. Concise and easy to read, the book quickly introduces basic concepts, then moves on to discuss target selection and the drug discovery process for both small and large molecular drugs.This second edition features many key enhancements, including Key Points, Chapter Summary, and Review Questions in each chapter, Answers to Review Questions provided in a book-end appendix, and one or two carefully selected \\\\\\\mini\\\\\\\ case studies in each chapter.Richly illustrated throughout with over ninety figures and tables, this important book also includes helpful listings of current FDA and European guidelines and a special section on regulatory authority and processes in China. It is an indispensable resource for pharmaceutical industry and academic researchers, pharmaceutical managers and executives, healthcare clinicians, policymakers, regulators, and lobbyists with an interest in drug development. It is also an excellent textbook for students in pharmacy, science, and medicine courses. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug development. Technology, Pharmaceutical. Chemistry, Pharmaceutical. Clinical Trials as Topic --methods. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | Book |
| Withdrawn status | Lost status | Damaged status | Not for loan | Home library | Current library | Shelving location | Date acquired | Source of acquisition | Total Checkouts | Full call number | Barcode | Checked out | Date last seen | Date last checked out | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dept. of Computational Biology and Bioinformatics | Dept. of Computational Biology and Bioinformatics | Processing Center | 05/01/2022 | MBC-0695/13 | 2 | 615.19 RIC-D | DCB2355 | 22/10/2023 | 24/07/2023 | 24/07/2023 | 19/07/2019 | Book | ||||
| Dept. of Computational Biology and Bioinformatics | Dept. of Computational Biology and Bioinformatics | Processing Center | 01/01/2016 | 3 | 615.19 RIC-D | DCB2354 | 01/09/2022 | 01/09/2022 | 19/07/2019 | Book |